NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CEFEPIME ALPHAPHARM contains the active ingredient cefepime hydrochloride Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Cefepime Alphapharm. It does…
Read More
Zavicefta
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ZAVICEFTA® This medicine is subject to additional monitoring in Australia. This will allow quickidentification of new safety information. You can help by reporting any side effectsyou may…
Read More
Ciprofloxacin Alphapharm
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. CIPROFLOXACIN ALPHAPHARM ciprofloxacin CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about CIPROFLOXACIN ALPHAPHARM. It does not contain all the available…
Read More
Neonatal antibiotic use associated with reduced growth in boys
Exposure to antibiotics in the first days of life is thought to affect physiological aspects of neonatal development. A new study, led by Bar-Ilan University’s Azrieli Faculty of Medicine, reveals that antibiotic treatment within 14 days of birth is associated…
Read More